Business
CSL (ASX:CSL) share price dips on latest AstraZeneca news
The CSL Limited (ASX: CSL) share price is down today as the Australian Government recommended that people under 50 should not take the AstraZeneca PLC (LSE: AZN) COVID-19 vaccine.
At the time of writing, shares in the pharmaceutical giant are trading for $264.20, down 0.65%. By comparison, the S&P/ASX 200 Index (ASX: XJO) is 0.43% lower.
With the latest vaccine developments potentially impacting the country’s return to post-COVID ‘normal’, the news may be behind today’s downward trend across the stock market.
Let’s take a closer look at last night’s developments and how the CSL share price is responding.
New vaccine recommendation
In another blow to the Federal Government’s delayed vaccine rollout (and the CSL share…
-
Noosa News15 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General19 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News24 hours agoTributes flow for Geham wife and mother after husband charged with murder
-
Noosa News15 hours agoHow to find out your TikTok personality – and become a ‘citizen scientist’